VyrarX

What you're buying

VyrarX sells three programs and the weight-loss one is two products: a semaglutide program and a tirzepatide program, both weekly injections, both physician-prescribed. The other two programs are anti-aging, which mixes tretinoin and topicals with NAD+ and longevity peptides, and recovery, which is sleep and inflammation protocols with lab work and follow-ups. There is no oral or sublingual GLP-1 here and no brand-name lane.

The weight-loss program is sold as more than a vial. VyrarX includes a personalized titration plan, one-to-one messaging with the prescribing provider, and nutrition coaching in the same price, with free shipping and no insurance involved. The corporate entity is named in the footer as VYRARX, INC., and the site carries a LegitScript link that resolves to the public certification checker rather than a self-hosted badge — a small thing, but it is the version a reader can verify.

What is missing is everyone's name. No compounding pharmacy is identified anywhere on the site, and no physician, medical director or provider group is named. The home page has an FAQ entry headed "Who are our pharmacies?" and another headed "Who is our provider network?", which is exactly the right pair of questions for a seller to answer — and both sit behind an accordion that adds nothing a reader could check.

What it costs (and how it's billed)

The two treatment cards on the home page carry the only figures VyrarX publishes: the semaglutide program is marked "FROM $179/mo" and the tirzepatide program "FROM $329/mo". Reading them in August 2026, there is no ladder underneath, no dose banding, no plan lengths and no indication of what the word "from" is doing. A reader cannot tell whether $179 is the first month, the lowest dose, or a prepay rung, because the page never says.

Two things can be said about those numbers with confidence. The first is that $179 a month for compounded semaglutide is competitive for a plan that bundles coaching and messaging. The second is that $329 a month for compounded tirzepatide is at the expensive end of a market where several sellers list the same molecule under $250 a month, and VyrarX charges more for tirzepatide than for semaglutide by a wider margin than most.

The billing terms are clearer than the prices. VyrarX runs subscription plans; you may cancel at any time, cancellation takes effect at the end of the current billing cycle, and refunds for a partial period are not given unless the law requires it. Once a prescription reaches the pharmacy and the medication ships, the order is generally non-refundable, with exceptions only for a damaged or defective delivery, a wrong medication or dose, or an order canceled before shipment. Refund requests go to care@vyrarx.com within 30 days, are processed within five to seven business days, and reach your card within five to ten more. The governing law is Delaware.

Who can order

The banner says "NOW TREATING IN 47 STATES" and the terms finally say which three are missing: VyrarX does not provide services in California, South Carolina or New Jersey. You must be at least 18 and resident in an eligible state. That list being in the terms rather than in the banner is a small failure of placement, but it is there and it is checkable, which was not true of this site earlier in the year.

Beyond residency, VyrarX makes the usual disclosure that a prescription is never guaranteed and that its providers make independent clinical decisions from what you tell them. It does not publish body-mass-index thresholds, contraindications, or which states require a live video visit, so the clinical gate is entirely invisible until you are inside the intake.

How the intake works

Four steps, and the site is specific about the timing of the one that matters. You complete a five-minute medical questionnaire from your phone; a licensed US physician reviews your history within 24 hours; if approved, medication and protocols ship free to your door; and then you message your care team with regular check-ins. The 24-hour review window is stated twice, once as a headline statistic and once in the steps, so it is a claim VyrarX is willing to be held to.

There is no video-visit requirement described anywhere, no appointment and no paperwork, which is the site's own summary of itself. Support is care@vyrarx.com, the same address as refunds, and there are no published hours or phone number.

What we'd want changed

Say what "from" means. Two numbers with a preposition in front of them is not pricing, and on a site whose home page badge reads "Transparent pricing" it is a claim the page does not keep. Whether $179 is a starting dose, an introductory month or a commitment rate changes what a reader should budget by hundreds of dollars a year, and VyrarX is the only party who knows.

Then fill in the two FAQ answers the site already wrote the questions for. "Who are our pharmacies?" and "Who is our provider network?" are the right questions, and a reader who opens them should come away with a compounder's name and a medical group's name. And $329 a month for tirzepatide needs either a justification on the page or a rethink, because as it stands the coaching and messaging that come with it are being asked to carry a lot of weight.

Bottom line

VyrarX is a tidy, fast, honestly documented small telehealth operation with a real refund policy, a named legal entity, a verifiable certification link and a 24-hour review promise — wrapped around pricing that stops one word short of being useful. If $179 a month for semaglutide turns out to be the standing rate at your dose, it is a good deal with coaching included; if it is a floor that rises, you will not find that out until the intake. The tirzepatide side is expensive enough that we would want the ladder in writing first.